Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Xynomic Pharmaceuticals Holdings, Inc.    XYN

XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

(XYN)
  Report
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
11/13/2020 11/16/2020 11/17/2020 11/20/2020 11/17/2020 Date
0(c) 2.6(c) 2.6(c) 0(c) 2.6 Last
100 531 129 15 129 Volume
-100.00% 0.00% -100.00% 0.00% Change
More quotes
Financials (USD)
Sales 2018 - - -
Net income 2018 -28,6 M - -
Net cash position 2018 1,62 M - -
P/E ratio 2018 -
Yield 2018 -
Sales 2019 - - -
Net income 2019 -25,1 M - -
Net Debt 2019 0,41 M - -
P/E ratio 2019 -5,00x
Yield 2019 -
Capitalization 120 M 120 M -
EV / Sales 2018 -
EV / Sales 2019 -
Nbr of Employees 31
Free-Float 19,9%
More Financials
Company
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. is a China-based biopharmaceutical company. The Company, together with its subsidiaries, are principally engaged in in-licensing, developing and commercializing oncology drug candidates in the People’s Republic of China (PRC), the United States, and rest of the world. To date, the Company has not yet generated any revenue from product sales. 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
06/29XYNOMIC PHARMACEUTICALS HOLDINGS, IN : Change in Directors or Principal Officers..
AQ
06/01XYNOMIC PHARMACEUTICALS : Management's Discussion and Analysis of Financial Cond..
AQ
05/14XYNOMIC PHARMACEUTICALS HOLDINGS, IN : Other Events (form 8-K)
AQ
03/30XYNOMIC PHARMACEUTICALS HOLDINGS, IN : Other Events (form 8-K)
AQ
03/27XYNOMIC PHARMACEUTICALS HOLDINGS, IN : Other Events (form 8-K)
AQ
More news
News in other languages on XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

- No features available -

More news
Chart XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
Duration : Period :
Xynomic Pharmaceuticals Holdings, Inc. Technical Analysis Chart | XYN | US98421X1028 | MarketScreener
Income Statement Evolution
Managers
NameTitle
Yinglin Mark Xu Chairman, President & Chief Executive Officer
Wentao Wu Chief Operating Officer
Jin Wei Kou Chief Financial & Accounting Officer
Bing Zhao Vice President-Clinical & Regulatory Affairs
Sophia Paspal Chief Development Officer
Sector and Competitors